Paul Tudor Jones Xeris Biopharma Holdings, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 507,357 shares of XERS stock, worth $1.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
507,357
Previous 573,186
11.48%
Holding current value
$1.74 Million
Previous $1.29 Million
12.1%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding XERS
# of Institutions
143Shares Held
60MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.6 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.5 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.9 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $466M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...